You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Cautious anticoagulation strategy in patients with dialysis-requiring end-stage kidney disease
  1. Jonathan M Behar1⇑,
  2. Suzanne H Forbes2,
  3. Andrew Wragg1,
  4. Simon Sporton1
  1. 1 Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK
  2. 2 Department of Nephrology, The Royal London Hospital, Barts Health NHS Trust, London, UK
  1. Correspondence to Dr Jonathan M Behar, Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; jonathan.behar{at}kcl.ac.uk

https://doi.org/10.1136/heartjnl-2017-311270

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    To the Editor: We read with interest this manuscript which demonstrated in a large clinical registry that patients with chronic kidney disease with indications for anticoagulation were often treated subtherapeutically.1 A more aggressive approach was, therefore, advocated.

    We would like to point out that, while this study should be commended for including a large number of patients, it did not …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.